{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:29:03Z","timestamp":1790152143777,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["RED-00059-23"],"award-info":[{"award-number":["RED-00059-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.prp.2024.155592","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T21:23:10Z","timestamp":1725744190000},"page":"155592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["TNFRSF10D expression as a potential biomarker for cisplatin-induced damage and ovarian tumor relapse prediction"],"prefix":"10.1016","volume":"263","author":[{"given":"Nikole Gontijo","family":"Gon\u00e7ales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan \u00d4rtero Perez","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Maria","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnaldo Lopes","family":"da Silva Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia","family":"da Concei\u00e7\u00e3o Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.prp.2024.155592_bib1","article-title":"Platinum resistance in ovarian cancer: role of DNA repair","author":"Damia","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155592_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2024.155592_bib3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.biopha.2017.12.082","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies","volume":"98","author":"Naimi","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.prp.2024.155592_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc.2017.28","article-title":"Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy","volume":"17","author":"von Karstedt","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2024.155592_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.molcel.2018.01.027","article-title":"Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2","volume":"69","author":"Annibaldi","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.prp.2024.155592_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-0270(99)00193-4","article-title":"Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?","volume":"96","author":"Lobner","year":"2000","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.prp.2024.155592_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.prp.2024.155592_bib8","doi-asserted-by":"crossref","first-page":"14701","DOI":"10.1038\/srep14701","article-title":"An automated fitting procedure and software for dose-response curves with multiphasic features","volume":"5","author":"Di Veroli","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155592_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.prp.2024.155592_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3802\/jgo.2012.23.3.182","article-title":"The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines","volume":"23","author":"Kim","year":"2012","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.prp.2024.155592_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310960","article-title":"Potentiation of cisplatin cytotoxicity in resistant ovarian cancer SKOV3\/cisplatin cells by quercetin pre-treatment","volume":"24","author":"Hasan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155592_bib12","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2020\/e1492","article-title":"Apoptosis-related gene expression can predict the response of ovarian cancer cell lines to treatment with recombinant human TRAIL alone or combined with cisplatin","volume":"75","author":"Braga","year":"2020","journal-title":"Clinics"},{"key":"10.1016\/j.prp.2024.155592_bib13","first-page":"117","article-title":"Cataloging antineoplastic agents according to their effectiveness against platinum-resistant and platinum-sensitive ovarian carcinoma cell lines","volume":"2","author":"Ishiguro","year":"2016","journal-title":"J. Transl. Sci."},{"key":"10.1016\/j.prp.2024.155592_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2022.151849","article-title":"Markers to sensibility and relapse on IMR-32 neuroblastoma cell line cultured in monolayer (2D) and neurosphere (3D) models cisplatin-treated","volume":"124","author":"Goncalves","year":"2022","journal-title":"Acta Histochem."},{"key":"10.1016\/j.prp.2024.155592_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2021.151768","article-title":"Phenotypic changes on central nervous system (CNS) tumor cell lines cultured in vitro 2D and 3D models and treated with cisplatin","volume":"123","author":"Perez Goncalves","year":"2021","journal-title":"Acta Histochem."},{"key":"10.1016\/j.prp.2024.155592_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104520","article-title":"Central nervous system (CNS) tumor cell heterogeneity contributes to differential platinum-based response in an in vitro 2D and 3D cell culture approach","volume":"116","author":"Goncalves","year":"2020","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.prp.2024.155592_bib17","first-page":"158","article-title":"Epithelial-to-mesenchymal transition markers are differentially expressed in epithelial cancer cell lines after everolimus treatment","volume":"20","author":"Goncalves","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155592_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4252\/wjsc.v6.i2.230","article-title":"Glioblastoma stem cells: molecular characteristics and therapeutic implications","volume":"6","author":"Bayin","year":"2014","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.prp.2024.155592_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.prp.2024.155592_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/mco.2017.1275","article-title":"Molecular genetics complexity impeding research progress in breast and ovarian cancers","volume":"7","author":"Gupta","year":"2017","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155592_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12032-017-0960-z","article-title":"A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer","volume":"34","author":"Oronsky","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2024.155592_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-2187-8-7","article-title":"TRAF molecules in cell signaling and in human diseases","volume":"8","author":"Xie","year":"2013","journal-title":"J. Mol. Signal."},{"key":"10.1016\/j.prp.2024.155592_bib23","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biocel.2007.02.007","article-title":"TRAIL signalling: decisions between life and death","volume":"39","author":"Falschlehner","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.prp.2024.155592_bib24","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/sj.onc.1204282","article-title":"Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways","volume":"20","author":"Suliman","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2024.155592_bib25","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1091\/mbc.e09-08-0715","article-title":"The scaffold protein TANK\/I-TRAF inhibits NF-kappaB activation by recruiting polo-like kinase 1","volume":"21","author":"Zhang","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.prp.2024.155592_bib26","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/bjc.2011.84","article-title":"Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis","volume":"104","author":"Duiker","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155592_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.22325","article-title":"Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L\/trail-Cisplatin combination therapy in cervical cancer","volume":"55","author":"Narayan","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2024.155592_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ygyno.2012.04.038","article-title":"TRAIL-R3-related apoptosis: epigenetic and expression analyses in women with ovarian neoplasia","volume":"126","author":"Braga Lda","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2024.155592_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133257","article-title":"Dying to survive\u2013the p53 paradox","volume":"13","author":"Lees","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155592_bib30","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1158\/0008-5472.CAN-04-1195","article-title":"p53 upregulates death receptor 4 expression through an intronic p53 binding site","volume":"64","author":"Liu","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2024.155592_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.prp.2024.155592_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12307-017-0203-z","article-title":"Three-dimensional cellular arrangement in epithelial ovarian cancer cell lines TOV-21G and SKOV-3 is associated with apoptosis-related mirna expression modulation","volume":"11","author":"de Lima","year":"2018","journal-title":"Cancer Microenviron."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382400503X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382400503X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T03:50:05Z","timestamp":1732333805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382400503X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"alternative-id":["S034403382400503X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155592","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNFRSF10D expression as a potential biomarker for cisplatin-induced damage and ovarian tumor relapse prediction","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155592"}}